Multipotent miRNA Sponge-Loaded Magnetic Nanodroplets with Ultrasound/Magnet-Assisted Delivery for Hepatocellular Carcinoma Therapy.

Molecular Pharmaceutics
Wei DongYujin Zong

Abstract

Gene therapy is likely to be the most promising way to tackle cancer, while defects in molecular strategies and delivery systems have led to an impasse in clinical application. Here, it is found that onco-miRNAs of the miR-515 and -449 families were upregulated in hepatocellular carcinoma (HCC), and the sponge targeting miR-515 family had a significant probability to suppress cancer cell proliferation. Then, we constructed non-toxic sponge-loaded magnetic nanodroplets containing 20% C6F14 (SLMNDs-20%) that are incorporated with fluorinated superparamagnetic iron oxide nanoparticles enhancing external magnetism-assisted targeting and enabling a direct visualization of SLMNDs-20% distribution in vivo via magnetic resonance imaging monitoring. SLMNDs-20% could be vaporized by programmable focused ultrasound (FUS) activation, achieving ∼45% in vitro sponge delivery efficiency and significantly enhancing in vivo sponge delivery without a clear apoptosis. Moreover, the sponge-1-carrying SLMNDs-20% could effectively suppress proliferation of xenograft HCC after FUS exposure because sponge-1-suppressing onco-miR-515 enhanced the expression of anti-oncogenes (P21, CD22, TIMP1, NFKB, and E-cadherin) in cancer cells. The current results i...Continue Reading

References

Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P L FelgnerM Danielsen
Feb 1, 1968·Journal of the National Cancer Institute·L A DethlefsenM L Mendelsohn
Aug 22, 1996·Nature·M S Chapman, I M Verma
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·S K HobbsR K Jain
Dec 22, 1998·Molecular and Cellular Biology·C V Dang
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H MaedaK Hori
Apr 28, 2000·Science·M Cavazzana-CalvoA Fischer
Oct 12, 2000·Cellular and Molecular Life Sciences : CMLS·I HellgrenC Sylvén
Feb 7, 2001·Genes & Development·S M ElbashirT Tuschl
Sep 5, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·I MoretS F Aliño
Apr 19, 2002·The New England Journal of Medicine·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Jan 24, 2003·Nature·Erika Check
Nov 5, 2003·Ultrasound in Medicine & Biology·Allan LawrieChristopher M Newman
Dec 20, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Anas El-Aneed
Apr 24, 2004·Science·Soraya YektaDavid P Bartel
Jul 14, 2004·Medicinal Research Reviews·Hai-sheng ZhouChih-chuan Liang
Nov 4, 2004·Trends in Genetics : TIG·Peizhang XuBruce A Hay
Mar 25, 2006·Nature Reviews. Cancer·Aurora Esquela-Kerscher, Frank J Slack
Aug 15, 2006·Biochemical and Biophysical Research Communications·Peter S VezeridisJenneke Klein-Nulend
Aug 29, 2006·Drug Discovery Today·Arun K IyerHiroshi Maeda
Nov 9, 2006·Proceedings of the National Academy of Sciences of the United States of America·S HorvathP S Mischel
May 1, 2007·Current Opinion in Genetics & Development·Michel GeorgesCarole Charlier
Jun 15, 2007·Biochemical and Biophysical Research Communications·Manabu Kinoshita, Kullervo Hynynen
Aug 19, 2007·Nature Methods·Margaret S EbertPhillip A Sharp
Dec 18, 2007·International Journal of Pharmaceutics·Ryo SuzukiKazuo Maruyama
Jan 15, 2008·Cell·Ana EulalioElisa Izaurralde
Jan 29, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jinmai JiangThomas D Schmittgen
Feb 2, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Roosmarijn E VandenbrouckeNiek N Sanders
Oct 29, 2008·Genome Research·Robin C FriedmanDavid P Bartel
Dec 2, 2008·Nature Methods·Bernhard GentnerLuigi Naldini
Mar 24, 2009·Methods in Molecular Biology·Olga MykhaylykChristian Plank
Aug 18, 2009·Nature Structural & Molecular Biology·Tomoko KawamataYukihide Tomari
Nov 13, 2009·Gene Therapy·S Nayak, R W Herzog
May 27, 2010·Cancer Research·Jen-Liang SuMien-Chie Hung
Sep 22, 2010·RNA·Margaret S Ebert, Phillip A Sharp
Nov 26, 2010·British Journal of Cancer·S Huang, X He
Dec 1, 2010·BMC Systems Biology·Hua DongMomiao Xiong
Dec 15, 2010·Current Protocols in Bioinformatics·Ben Langmead

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2021 Meta ULC. All rights reserved